We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 21 results
  1. Tuberculosis Vaccine: Past Experiences and Future Prospects

    Vaccines are the best prophylactic measure that have eradicated several diseases like polio, measles, and small pox. Currently, efficient vaccines...
    Chapter 2019
  2. Pulmonary non-tuberculous mycobacterial infections: current state and future management

    Currently, there is a trend of increasing incidence in pulmonary non-tuberculous mycobacterial infections (PNTM) together with a decrease in...

    Kai Ling Chin, Maria E. Sarmiento, ... Armando Acosta in European Journal of Clinical Microbiology & Infectious Diseases
    Article 18 December 2019
  3. Non-small Cell Lung Cancer

    Non-small cell lung cancer (NSCLC) is most common cause of cancer death in the world. Early detection, diagnosis and treatments are the essential...
    Apichat Tantraworasin, Sarawut Kongkarnka, ... Busayamas Chewaskulyong in International Manual of Oncology Practice
    Chapter 2019
  4. Cancer Immunotherapy: Friend or Foe of Mental Health?

    Cancer morbidity with mental healthMental health problems is of utmost importance due to its considerable impact on mortality. Clinical trials...
    Amene Saghazadeh, Nima Rezaei in Cancer Genetics and Psychotherapy
    Chapter 2017
  5. Immune Therapy

    Lung cancer has long been considered an unsuitable target for immunotherapy due to its proposed immunoresistant properties. However, recent evidence...
    Lysanne Lievense, Joachim Aerts, Joost Hegmans in Lung Cancer and Personalized Medicine
    Chapter 2016
  6. Lung Cancer: Diagnosis and Treatment Approach

    Lung cancer is one of the most common causes of cancer death in the world. There are many risk factors for lung cancer including tobacco smoking,...
    Apichat Tantraworasin, Thatthan Suksomboonchroen, ... Busayamas Chewaskulyong in International Manual of Oncology Practice
    Chapter 2015
  7. Biological therapy of lung cancer

    Bacillus Calmette Guerin (BCG) was the first biotherapy tested in lung cancer in the modern era. Early randomized trials suggested that various forms...
    Robert O. Dillman in Principles of Cancer Biotherapy
    Chapter 2009
  8. Immunotherapeutical Potential of Mycobacterium Vaccae on M. Tuberculosis Infection in Mice

    Tuberculosis remains the worldwide infectious disease. To identify the therapeutic potential of M. vaccae in treating tuberculosis, M. vaccae was...

    Lijun Xu, Yanyan Wang, ... Haiming Wei in Cellular & Molecular Immunology
    Article 01 February 2009
  9. The hygiene hypothesis and affective and anxiety disorders

    Chronic inflammatory disorders are increasing in prevalence in the developed countries. The hygiene hypothesis proposes that our changing microbial...
    Graham A. W. Rook, Christopher A. Lowry in The Hygiene Hypothesis and Darwinian Medicine
    Chapter 2009
  10. Prostate Cancer Vaccines

    Standard systemic treatment of prostate cancer today is comprised of antihormonal and cytostatic agents. Vaccine therapy of prostate cancer is...

    Christian Doehn, Torsten Böhmer, ... Dieter Jocham in BioDrugs
    Article 01 March 2008
  11. Clinical and immunological assessment of Mycobacterium vaccae (SRL172) with chemotherapy in patients with malignant mesothelioma

    The objectives of this study were to determine the toxicity of intratumoural/intrapleural SRL172 in addition to intradermal SRL172 and standard...

    R Mendes, M E R O'Brien, ... B E Souberbielle in British Journal of Cancer
    Article Open access 11 February 2002
  12. A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma

    Mycobacterial preparations have been used with limited success against cancer apart from superficial bladder cancer. Recently, a therapeutic vaccine...

    M E R O'Brien, A Saini, ... B E Souberbielle in British Journal of Cancer
    Article Open access 05 September 2000
  13. The immunotherapy of prostate cancer

    Advanced prostate cancer remains incurable with standard treatment options. Immunotherapy may be a realistic alternative given the growing evidence...

    AG Dalgleish, MJA Perry, ... RS Kirby in Prostate Cancer and Prostatic Diseases
    Article 12 January 2001
  14. Prospects for the Development of New Vaccine Adjuvants

    This review focuses on the impact of various new adjuvant formulations on the efficacy of existing and new human vaccines.

    Despite major advances in...

    John C Cox, Alan Coulter in BioDrugs
    Article 01 December 1999
  15. Th1/Th2 balance in cancer, transplantation and pregnancy

    Michael R. Shurin, Lina Lu, ... Michael T. Lotze in Springer Seminars in Immunopathology
    Article 01 December 1999
Did you find what you were looking for? Share feedback.